Resumen El trasplante renal en pediatria representa la modalidad óptimade manejo de la insuficiencia renal crónica, ya que permite recuperar en diversos grados las severas complicaciones propias de la uremia, especialmente el retraso del crecimiento
descargar 101.97 Kb.
|
Referencias Fine RN: Renal transp1antation for chi1dren-the only realistic choice. Kidney Int 1985; 28: S-15. Fine R, Tejani A: Renal transplantation in children, Nephron 1987;47: 81. 3. Browndridge G, Fielding D: Psychosocial adjustment to end-stage renal failure: comparing haemodialysis, continous ambu1atory peritoneal dialysis and transplantation. Pediatr Nephro11991; 5: 612-6. 4. Morel P, Almond PS, Matas AJ, et al. Long-term quality of life after kidney transplantation inchildhood. Transplantation 1991; 52: 47-53. [ Links ] 5. Potter DE, Najarian J, Belzer F, Holliday MA, Homs G, Salvatierra O: Long term results ofrenal transplantation in children. Kidney Int 1991; 40: 752-6. [ Links ] 6. Potter DE. Long-Term Outcome of kidney transplantation in children. En: Tejani AH, Fine RN, editores. Pediatric Renal Transplantation, 1 ed. New York: Wiley-Liss, Inc. 1994: 525-533. 7. French JH, Rapin I, Martinez WC. Neurologic complications of renal failure and their treatment. En: Edelmann CM Jr, editor. Pediatric Kidney Disease. 2nd ed. 1992: 695-723. 8. Cohn RA: Premptive transplantation. En: Tejani AH, Fine RN, editores. Pediatric Renal Transplantation.1 th ed. New York: Wiley-Liss, Inc. 1994: 87-93. 9. Fine RN, Ettenger R: Renal transplantation in chi1dren. En: Morris PJ editor. Kidney Transplantation. 4th ed. Philadelphia: W.B. Saunders Company, 1994: 412-459. 10. Najarian JS, Almond PS, Mauer M, et al. Renal transplantation in the first year of life: The treatment of choice for infants with endstage renal disease. J Am Soc Nephrol 1992; 2 (Supp1): 228. [ Links ] 11. Najarian JS, Almond PS, Gilligham KJ, et al: Renal transplantation in the first five years oflife. Kidney 1nt 1993; 44 (Suppl. 43): 40-4. 12. Tejani A, Sullivan K: Long-term follow-up of growth in children post-transp1antation. Kidney Int 1993; 44 (Suppl43): 56-58. 13. Wolff G: Pretransp1antation and posttransp1antattion psychosocial eva1uation En: Tejani AH, Fine RN, editores. Pediatric Renal Transp1antation. 1 ed. New York: Wiley-Liss, Inc. 1994: 109-135. 14. Broyer M, Ehrich J, Jones E, Selwood N: Five year survival ofkidney transp1antation in children: Data from the European (EDTA-ERA) Registry.Kidney Int 1993; 44 (Suppl43): 22-5. 15. Waradley BA, HébertD, Sullivan EK, Alexander SR, TejaniA: Renal transplantation. chronic dialysis, and chronic renal insufficiency in children and adolescents, The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephro11997; 11: 49-64. 16. Benfield MR, McDonald R, Sullivan EK, Stablein DM, Tejani A: The 1997 annual renal transp1antation in chi1dren report of North American Pediatric Renal Transp1ant Cooperative Study (NAPRTCS). Pediatr Transplant 1999; 3: 152-67. 17. Millan MT, Sarwal MM, Lernley KV, Yorgin P, Orlandi P, So S, Alexander S, Salvatierra O-Jr: A 100% 2 year graft survival can be attained in high-risk 15-kg or smal1er infant recipients of kidney allografts. Arch Surg 2000; 135: 1063-8. [ Links ] 18. Arbus GS, Hébert D: Impact of recipient age on renal allograft outcome. En: Tejani AH, Fine RN, editores. pediaJic Renal Transplantation.lthed. New York: Wiley-Liss, Inc. 1994: 165-185. 19. Ettenger R, Blifeld C, Prince H, et al: The pediatric nephrologist in dilernma: Growth afier transplantation and its interaction with age as a possible inmunologic variable. J Pediatr 1987; 111: 1022-5. 20. Ettenger RB: Children are different: the challenges of pediatric renal transplantation. Am J Kidney Dis 1992; 20: 668-72. [ Links ] 21. Ettenger RB:Improving the utilization of cadaver kidneys in childer. Kidney Int 1993; 44 (Suppl 43): 99-103. [ Links ] 22. Tejani A, Stablein D, Alexander S, Fine R, Harmon W: Analysis of rejection outcomes and implications Areport of TheNorth American Pediatric Renal Transplant Cooperative Study. Transplantation 1995;59: 500-4. [ Links ] 23. Alexander SR, Arbus GS, Butt KMH, et al. The 1989 report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephro 1990; 4: 542-53. [ Links ] 24. Kohaut EC, Tejani A: The 1994 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. PediatrNephro 1996;10: 422-34. [ Links ] 25. Gagnadoux MF, Niaudet P, Broyer M: Non-irnmunological risk factors in paediatric renal transplantation. Pediatr Nephrol 1993; 7: 89-95. 26. Jones JW, Matas AJ, Najarian JS: Surgical Technique. En: Tejani AH, Fine RN, editores. Pediatric Renal Transplantation. 1 ed. New York: Wiley-Liss, Inc. 1994: 187-200. 27. Matas AJ, Chavers BM, Nevins TE, Mauer SM, Kashtan CE, Cook M, Najarian JS: Recipient evaluation, preparation, and care in pediatric transplantation: The University of Miunesota protocols. Kidney Int 1996; 49 (Suppl. 53): 99-102. [ Links ] 28. Ettenger R, Rosenthal J, Marik J, et al: Improved cadaver renal transplant outcome in children. Pediatr Nephro 1991; 5: 137-42. [ Links ] 29. Informe anual. Corporación de fomento del trasplante de Chile 2000:16. [ Links ] 30. Delucchi A, Rodríguez E, Cano F, Wolff E: Focal segmental glomeruloesc1erosis relapse after trasplantation: treatrnent with high cyclosporine doses and a short plasmapheresis course. Pediatr Nephro11994; 8: 786-87. 31. Michon I, Hamburguer J, Oeconomos N, et al: Une tentative de transplantation renale chez l'homme: aspects medicaux et biologique. Presse Med 1953; 61: 1419-23. [ Links ] 32. Starlz Te, Marchioro TL, Porter KA, Tanous DF, Carey T: The role of organ transplantation inpediatrics. Pediatr Clin North Am 1966;13: 381-422. . [ Links ] 33. Ettenger RB, Rosenthal JT, Marik J, Grimm PC, Nelson P, Malekzadeh MH, Fine R: Long-term results with cyc1osporine irnmune suppression in pediatric cadaver renal transplantation. Transplant Proc 1991; 23: 1011-2. 34. Suthanthiran M, Strom T: Renal transplantation . N E J M 1994; 331: 365-73. [ Links ] 35. Hirata M., Terasaki P: Pediatric renal transplantation. In; Terasaki and Cecka editores. Clinical Transplants, UCLA Tissue Typing Laboratory, Los Angeles, CA.: 1994: 395-401. 35. Sollinger H.: for the US Renal Transplant Mycophenolate Study Group. MMF for the prevention of acute rejection in primary cadaverlc renal allografi recipients. Transplantation 1995; 60: 225-32. [ Links ] 36. European MMF Co-operative Study group. Placebo controlled study of MMF combined with cyc1osporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345:1321-5. 37. Ettenger R, Cohen A, Nast C, Moulton L, Marik J, Gales B: Mycophenolate mofetil as maintenance irnmunosup-pression in pediatric renal transplantation. Transplant Proc 1997; 29:340-1. [ Links ] 38. Vester U, Kranz Testa G, Malago M, Beelen D, Broelsch C, Hoyer P: Efficacy and tolerability of interleukin-2 receptor blockade with basiliximab in pediatric renal transplant recipients. Pediatr Transplantation 2001; 5: 297-301. [ Links ] 39. Danovitch G: Irnmunosuppressive medications and protocols for kidney transplantation. In: Danovitch G. Handbook of Kidney Transplantation 2000, Ed, Little Brown and company, Boston, New York, Sd Ed. 2000: 55-9. 40. Tejani A: The impact of acute rejection on chronic rejection: a report of the NorthAmerican Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2000; 4: 107-111. [ Links ] 41. Nahan R, Moore R, Amlot P,Schmidt A, Abeywickrama K, Soulillou J, and the CHIB 201 Intemational Study Group: Randomized trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. Lancet 1997; 350: 1193-8. [ Links ] 42. Kahan B, Rajagopalah P, Hall M, and the US Simulect Renal study Group: Reduction of the ocurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric antiinterleukin 2 receptor monoc1onal antibody. Transplantation 1999;67: 276-84. 43. Ettenger R, Blifeld C, Prince H: The pediatric nephrologist in dilernma: Growth aftertransplantation and its interaction with age as a possible inmunologic variable. J Pediatr 1987; 111: 1022-5. [ Links ] 44. Fine RN, Ettenger R: Renal transplantation in children. En: Morris PJ editor. Kidney Transplantation. 4th ed. Philadelphia: W.B. Saunders Company, 1994: 412-59. 45. Arbus GS, Hébert D: Impact of recipient age on renal allograft outcome. En: Tejani AH, Fine RN, editores. Pediatric Renal Transplantation.lth ed. New York: Wiley-Liss, Inc. 1994: 165-85. 46. Tejani A, Stablein D, Alexander S, Fine R, Harmon W: Analysis of rejection outcomes and implications -Areport ofThe NorthAmerican Pediatric Renal TransplantCooperative Study. Transplantation 1995;59: 500-4. [ Links ] 47. Snydman DR: Epidemiology of infections after solid-organ transplantation. Clin Infect Dis 2001; 33 (suppl1): S5-S8. [ Links ] 48. Waradley BA, HébertD, Su11ivan EK, Alexander SR, Tejani A: Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephro11997; 11: 49-64. 49. Muñoz P: Management of urinary tract infections and lynphocele in renal transplant recipients. Cin Infects Dis 2001; 33 (suppl 1): 53-7. 50. Tolkoff-Rubin NE, Rubin RH: Urinary tract infection in the inmunocompromised host: lessons from kidney transplantation and the AIDS epidemic. Infect Dis Clin NorthAm 1997; 11: 707-17. [ Links ] 51. Sharifian M, Rees L, Trompeter RS: High incidence of bacteriuria following renal transplantation in children. Nephrol Dial Transplant 1998; 13: 432-5. [ Links ] 52. Takai K, Aoki A, Suga A, Tollemar J, Wilczek HE, Naito K, Groth CG: Urinary tract infections following renal transplantation. Transplant Proc 1998; 165: 3140-1. [ Links ] 53. Rabkin DG, Stifelman MD, BirkhoffJ,et al: Early catheter removal decreases incidence of urinary tract infections in renal transplant recipients. Transplant Proc 1998; 30: 4314-6. [ Links ] 54. Fox BC, Sollinger HW, Belzer FO, Maki DG: A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absortion of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 1990; 89: 255-74. [ Links ] 55. Moisés Neto M, Costa RS, Reis MA, et al: Use of ciprofloxacin as prophylactic agent in urinary tract infections in renal transplant recipients. Clin Transplant 1997; 11: 446-52. [ Links ] 56. Avery RK: The relationship between cytomegalovirus and chronic allograft dysfunction. Medscape 2000 sept. Available from: http://www.medscape.com/Medscape/transplantation/ClinicalMgmt/ CM.v07/public/index-CM.v07.htmI. 57. Tolkoff-Rubin NE, Rubin RH: Recent advances in diagnOSiS and management of infection-in tbe organ transplant recipient. Sem Nepbro12000; 20: 148-63. 58. Paya CV: Prevention of cytomegalovirus disease in recipients of solid-organ transplant. Cin Infects Dis 2001; 32:596-603: [ Links ] 59. Singh N. Preemptive tberapy universal prophylaxis witb ganciclovir for cytomegalovirus in solid organ transplant recipients, Cin lnfects Dis 2001; 32: 742-51. 60. Van de Bij W, Speich R: Management of cytomega-Iovirus infection and disease after solid-organ transplantation. Cin Infects Dis 2001; 33 (suppl 1): 32-7. 61. Bakir N, Sluiter WJ, Ploeg RJ, van Son WJ, Tegzess AM: Primary renal transplant thrombosis in children. Nephrol Dial Transplant 1996; 11: 140-7. [ Links ] 62. Parrot NR: Early graft loss: the Cinderella of transplantation. Nephrol Dial Transplant 1995; 10 (Suppl 1): 32-5. [ Links ] 63. Harmon WE, Stablein D, Alexander ST, Tejani A: Graft thrombosis in pediatric renal transplant recipients-A report of The North American Pediatric Renal Transplant Cooperative Study. Transplantation 1991; 51: 406-12. [ Links ] 64. Singh A, Stablein D, Tejani A: Risk factors for vascular tbrombosis in pediatric renaltransplantation. A special Report of The North American Pediatric Renal Transplant Cooperative Study. Transplantation 1997; 63: 1263-7. [ Links ] 65. Penny MJ, Nankivell BJ, Disney AP, Bytb K, Chapman JR: Renal graft tbrombosis. Transplantation 1994; 58: 565-9. [ Links ] 66. Harmon WE, Alexander ST,Tejani A, Stablein D: The effect of donor age on graft survival in pediatric cadaver renal transplant recipients A report of The North American Pediatric Renal Transplant Cooperative Study. Transplantation 1992; 54: 232-7. [ Links ] 67. Broyer M, Gagnadoux MF, Sierro A, Niaudet P: Utilisation d'hparine de bas poids moléculaire IItitre préventifdaos les greffes rénales chez l'enfant. Procedente de-el Sentinaire de Nephrologie Pediatrique. Hospital Necker-Enfants Malades; 1990 Marzo 26-27; Paris, Francia; 1990: 34-8. 68. van Lieburg A, de Jong M, Hoitsma F, Buskens F, Schroeder C, Monnens L: Renal transplant tbrombosis in children. J Ped Surgery 1995; 30: 615-9. [ Links ] 69. Heidenreich S, Dercken C, August C, Koch HG, Nowak-gottl U: Hight rate of acute rejections in renal allograft recipients witb tbrombophilic risk factors. J Am Soc Nephrol 1998; 9: 1309-13. 70. Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R: Noncompliance in renal transplant recipients: Evaluation by socioeconontic groups. Transplant Proc 1989; 21: 3979-81. [ Links ] 71. Cole BR: Noncompliance to medical regimens. En: TejaniAH, Fine RN, editores. Pediatric Renal Transplantation. lth ed. New York: Wiley-Liss, Inc. 1994: 397-408. |
